SEC FORM 4
$847,758.48
Monopar Therapeutics (MNPR)
Sale of 9,638 shares at $87.96 per share.
Reporting Person Robinson Chandler · Officer Title Chief Executive Officer · Transaction Code S
Traded Sep 24, 2026 · Disclosed Sep 28, 2026
Source: SEC Form 4 · 0001437749-26-031411 · filed 2026-09-28 · View filing →